2017 American Transplant Congress

Sunday, April 30, 2017

4:54pm-5:06pm

A Prospective Iterative Trial of Carfizomib-Based Desensitization Trial: Initial Comparative Observations.

S. Tremblay,¹ A. Shields,^1,2 R. Alloway,¹ P. Brailey,¹ A. Leino,¹ A. Lichvar,¹ B. Abu Jawdeh,¹ J. Driscoll,¹ A. Girnita,¹ E. Woodle.¹

Concurrent Session: Clinical Science: Kidney Immunosuppression: Desensitization  •  E354b

4:54pm-5:06pm

Addition of FEV1 Drop to LAS May Improve Access of CF Patients to Transplant: Analysis of the SRTR and US CF Foundation Patient Registries.

E. Dasenbrook,¹ M. Skeans,² A. Fink,³ B. Marshall,³ M. Valapour.^1,2

Concurrent Session: Lung Transplantation from Donation to Retransplantation  •  E270

4:54pm-5:06pm

Baseline Immune Assessment to Individualize Immunosuppression in SPK Recipients with Type 1 Diabetes.

Y. Kudva, V. Dadlani, A. Miller, M. Abdallah, W. Kremers, M. Stegall, R. Abraham.

Concurrent Session: Pancreas Transplantation  •  E267

4:54pm-5:06pm

Causes and Long-Term Consequences of Diarrhea After Kidney Transplantation.

A. Devresse,¹ F. Aulagnon,² A. Scemla,² L. Morin,² F. Lanternier,³ D. Anglicheau,² O. Lortholary,³ C. Legendre,² V. Avettand-Fenoel,⁴ J. Zuber.²

Concurrent Session: Kidney Clinical Complications 1  •  E354a

4:54pm-5:06pm

Circulating Inflammatory Factors in Deceased Organ Donors Result in Innate Immune Activation.

T. Brennan, L. Lin, J. Pollara.

Concurrent Session: Innate Immunity  •  E350

4:54pm-5:06pm

Direct Acting Antiviral Drugs Are Highly Effective in Hepatitis C (HCV) Patients with End Stage Renal Disease (ESKD) and Advanced Liver Disease (ALD).

J. Korula, T. Shah, E. Ranger, E. Barba, D. Vu, R. Naraghi.

Concurrent Session: Liver: Viral Hepatitis  •  E271a

4:54pm-5:06pm

Is Deceased Donor Kidney Transplantation (DDTX) Justified in Patients with More Than 10 Years of Pre-TX Dialysis Exposure?

C. Rose, J. Gill, J. Lesage, Y. Joffres, J. Gill.

Concurrent Session: Kidney Allocation: Changes and Consequences  •  E450a

4:54pm-5:06pm

Multiple Dosing of Anti-C1s Antibody TNT009 – Effect on HLA Antibody-Triggered Complement Activation in Healthy Volunteers and Kidney Transplant Recipients with Antibody-Mediated Rejection.

J. Muhlbacher,¹ B. Jilma,² M. Wahrmann,³ F. Eskandary,³ J. Gilbert,⁴ S. Panicker,⁴ G. Böhmig.³

Concurrent Session: Novel Immunosuppression - DSA Monitoring  •  E450b

4:54pm-5:06pm

Non-Invasive Detection of Rejection with ImmunoPET Imaging.

D. Mathews,¹ K. Lindsay,² P. Santangelo,² Y. Dong,¹ J. Tso,³ A. Adams.¹

Concurrent Session: T Cell Biology and Alloimmunity  •  E352

4:54pm-5:06pm

Normothermic Regional Perfusion of Donors Following Circulatory Death Improves Outcomes in Liver Transplantation.

E. Mowlem,¹ L. Randle,² C. Fear,¹ K. Crick,¹ S. Messer,⁴ S. Large,⁴ A. Butler,³ C. Watson.³

Concurrent Session: Liver Allocation, Utilization, and Machine Perfusion  •  E451a